Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Johnson & Johnson highlights innovative neuropsychiatry portfolio and pipeline at Psych Congress
08:00am, Thursday, 24'th Oct 2024
New five-year data reinforce long-term safety and efficacy of SPRAVATO® (esketamine) in patients with inadequate response to two or more oral antidepressants (treatment-resistant depression) 23 ab
Johnson & Johnson Preferred Financing, Inc. Implements 2iG's PFC Insight
11:15am, Wednesday, 23'rd Oct 2024
PHILADELPHIA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- 2iG Solutions, Inc. (2iG or 2iG Solutions), provider of leading-edge data analytics and artificial intelligence (AI) reporting software, is pleased to a
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:05am, Wednesday, 23'rd Oct 2024
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
All It Takes Is $2,500 Invested in Each of These 3 High-Yield Dow Dividend Stocks to Help Generate Over $300 in Passive Income Per Year
05:40pm, Saturday, 19'th Oct 2024
Investors looking for dividend stocks at reasonable valuations have come to the right place.
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
09:57am, Saturday, 19'th Oct 2024
These companies' longtime shareholders have generally been rewarded.
Johnson & Johnson: Q3 Earnings Highlights Resilience And New Growth
08:44am, Saturday, 19'th Oct 2024
J&J's Q3 2024 earnings beat expectations with $22.5B in revenue, driven by strong performances from Darzalex, STELARA, and MedTech, despite ongoing challenges. The company updated its full-year guidan
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
02:34pm, Friday, 18'th Oct 2024
BofA Securities has upgraded Tyra Biosciences TYRA, a clinical-stage biotechnology company focused on developing next-generation precision medicines.
J&J's Q3 Earnings & Sales Top: Time to Buy, Sell or Hold the Stock?
10:20am, Friday, 18'th Oct 2024
JNJ beats third-quarter estimates for both earnings and sales. Those who already own J&J's stock may stay invested.
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
05:10am, Friday, 18'th Oct 2024
These stocks could deliver big over the long term.
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
01:59pm, Thursday, 17'th Oct 2024
Johnson & Johnson's JNJ stock price advance has been reinvigorated. The stock price rally stalled a few years ago due to the COVID-19 bubble bursting and the divestiture of Kenvue KVUE, but those days
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike
01:11pm, Thursday, 17'th Oct 2024
Johnson & Johnson infused positive optimism after posting solid third-quarter 2024 earnings. A few analysts raised their target price on the stock.
What's Next For Johnson & Johnson Stock?
07:00am, Thursday, 17'th Oct 2024
Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates. The company reported revenue of $22.5 billion and adjusted earnings of $2.42 per sha
This Magnificent Dividend Stock Is as Healthy as It Gets
04:14am, Thursday, 17'th Oct 2024
Johnson & Johnson's latest financial checkup shows it's still in excellent health.
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
07:45am, Wednesday, 16'th Oct 2024
Johnson & Johnson's NYSE: JNJ stock price advance has been reinvigorated. The stock price rally stalled a few years ago due to the COVID-19 bubble bursting and the divestiture of Kenvue NYSE: KVUE, bu
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
05:27am, Wednesday, 16'th Oct 2024
Third-quarter results exceeded estimates, but the company also lowered overall earnings expectations for 2024.
